These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 33199208)

  • 21. Compliance of Antihypertensive Medication and Risk of Coronavirus Disease 2019: a Cohort Study Using Big Data from the Korean National Health Insurance Service.
    Kim J; Kim DW; Kim KI; Kim HB; Kim JH; Lee YG; Byeon KH; Cheong HK;
    J Korean Med Sci; 2020 Jun; 35(25):e232. PubMed ID: 32597045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertension, a Moving Target in COVID-19: Current Views and Perspectives.
    Savoia C; Volpe M; Kreutz R
    Circ Res; 2021 Apr; 128(7):1062-1079. PubMed ID: 33793331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin converting enzyme 2 at the interface between renin-angiotensin system inhibition and coronavirus disease 2019.
    Siri-Angkul N; Chattipakorn SC; Chattipakorn N
    J Physiol; 2020 Oct; 598(19):4181-4195. PubMed ID: 32710575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System.
    Pucci F; Bogaerts P; Rooman M
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33265982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
    Simko F; Baka T
    Clin Sci (Lond); 2021 Apr; 135(8):1009-1014. PubMed ID: 33881142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
    Shukla AK; Banerjee M
    High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19.
    Kai H; Kai M
    Hypertens Res; 2020 Jul; 43(7):648-654. PubMed ID: 32341442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future.
    Zhang J; Wang M; Ding W; Wan J
    Life Sci; 2020 Sep; 257():118142. PubMed ID: 32712300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 and renin-angiotensin system modulators: what do we know so far?
    de la Cruz A; Ashraf S; Vittorio TJ; Bella JN
    Expert Rev Cardiovasc Ther; 2020 Nov; 18(11):743-748. PubMed ID: 32842817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.
    Kreutz R; Algharably EAE; Azizi M; Dobrowolski P; Guzik T; Januszewicz A; Persu A; Prejbisz A; Riemer TG; Wang JG; Burnier M
    Cardiovasc Res; 2020 Aug; 116(10):1688-1699. PubMed ID: 32293003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.
    Brojakowska A; Narula J; Shimony R; Bander J
    J Am Coll Cardiol; 2020 Jun; 75(24):3085-3095. PubMed ID: 32305401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
    Trifirò G; Massari M; Da Cas R; Menniti Ippolito F; Sultana J; Crisafulli S; Giorgi Rossi P; Marino M; Zorzi M; Bovo E; Leoni O; Ludergnani M; Spila Alegiani S;
    Drug Saf; 2020 Dec; 43(12):1297-1308. PubMed ID: 32852721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renin-Angiotensin-Aldosterone Inhibitors and COVID-19 Infection.
    Tsampasian V; Corballis N; Vassiliou VS
    Curr Hypertens Rep; 2022 Oct; 24(10):425-433. PubMed ID: 35716247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
    Malek Mahdavi A
    Rev Med Virol; 2020 Sep; 30(5):e2119. PubMed ID: 32584474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.
    Dworakowska D; Grossman AB
    J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32633235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of renin-angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials.
    Lee MMY; Kondo T; Campbell RT; Petrie MC; Sattar N; Solomon SD; Vaduganathan M; Jhund PS; McMurray JJV
    Eur Heart J Cardiovasc Pharmacother; 2024 Jan; 10(1):68-80. PubMed ID: 37740450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
    Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
    Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    Pranata R; Permana H; Huang I; Lim MA; Soetedjo NNM; Supriyadi R; Soeroto AY; Alkatiri AA; Firman D; Lukito AA
    Diabetes Metab Syndr; 2020; 14(5):983-990. PubMed ID: 32615377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.